Showing posts with label Vytorin. Show all posts
Showing posts with label Vytorin. Show all posts

Wednesday, May 07, 2008

Question Authority coverage of Schering-Plough/Vytorin scandal sparks U.S. Attorney interest.

How do we know this? Well, not only have we recevied a lot of interesting stats over the last few months, but now the eminent blog Shearlings got Plowed has analyzed their readership and been able to pinpoint that the reader was . . . Assistant U.S. Attorney Robert Kirsch, of the Securities and Health Care Fraud Unit of the U.S. Attorney's Office, United States Department of Justice, District of New Jersey, 970 Broad Street, Seventh Floor, Newark, New Jersey.

Pretty cool, and you simply have to read that story!

What most readers may not have realized is that according to the data from Shearlings got Plowed, more specifially the navigation path of Robert Kirsch, he started out his search on . . . Question Authority:


Date Time Web Page

[Referring Page:]

24th April 2008 05:16:37 PM peterrost.blogspot.com/

[Entry Page:]

shearlingsplowed.blogspot.com/

24th April 2008 05:19:01 PM shearlingsplowed.blogspot.com/

shearlingsplowed.blogspot.com/2008/04/case-for-scrutinizing-analyst-opinions.html

24th April 2008 05:19:06 PM shearlingsplowed.blogspot.com/2008/04/case-for-scrutinizing-analyst-opinions.html

shearlingsplowed.blogspot.com/2008/04/to-more-clearly-explain-sen-grassleys.html

24th April 2008 05:20:32 PM shearlingsplowed.blogspot.com/2008/04/to-more-clearly-explain-sen-grassleys.html

shearlingsplowed.blogspot.com/2008/04/to-more-clearly-explain-sen-grassleys.html

[snip]

There's a ton more, but you get the idea.
And of, course, Ed has the full story about Schering-Plough's recent filing showing the government's interest in what may be hiding over at Kenilworth.

Tuesday, April 29, 2008

One picture says more than . . .



This image was taken with a cell phone, by someone passing by the doctor's lounge area yesterday ~2pm.

It shows how Schering-Plough and Merck are addressing the "communication problem" caused by the Enhance trial and dropping sales of Vytorin and Zetia.